Radnor, Pennsylvania-based Mineralys is a clinical-stage biopharmaceutical company developing treatments for hypertension, ...

Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a pioneering Ripasudil-Timolol combination therapy for ...

Study estimates the global lifetime risk and benefits of modifying cardiovascular risk factors like hypertension, smoking, ...

High blood pressure is often referred to as the “silent killer” for good reason. Too often, people have no idea they are at ...

To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...

High blood pressure increases the risk of developing metabolic syndrome, a group of health conditions that can lead to heart ...

Sotatercept, an activin signaling inhibitor, was associated with improved outcomes in patients with advanced pulmonary ...

So, taking all of that into account, the best time to take your blood pressure for most people will be in the morning — more ...

Marc Humbert, M.D., Ph.D., professor of respiratory medicine at Université Paris-Saclay and Inserm, believes that recent ...

Among patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood ...

Discover the key information about cardiovascular disease in Black men, including risk factors, prevention strategies, and ...

The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so ...